Day 3 – Monday, October 20

OPENING GENERAL SESSION

"Retinoblastoma is a remarkable ophthalmology success story in which the efforts of ophthalmologists, ophthalmic pathologists, and research scientists have led to understanding of the basic mechanisms of cancer and targeted therapies that are able to cure a once incurable tumor," said Hans E. Grossniklaus, MD, MBA. » Read more of Dr. Grossniklaus' remarks

Electronic Health Records, the Affordable Care Act, and Meaningful Use. The ophthalmology profession has seen its fair share of challenges over the past year, but Gregory L. Skuta, MD said despite these complications, the field has made great achievements and has had many successes. » Read more of Dr. Skuta's remarks

SURGERY

Patients who undergo second eye cataract surgery benefit with improvements in visual function and quality of life to levels beyond those obtained after first eye cataract surgery, said Nakul Shekhawat, MD. » Read Dr. Shekhawat's analysis

Results of a retrospective cohort analysis including data from more than 129,000 eyes that underwent clear corneal phacoemulsification reinforce the efficacy of intracameral antibiotic injection for preventing postoperative endophthalmitis, said Neal Shorstein, MD. » Read the results

Findings from a mid-term evaluation of the first DMEK cohort show that the procedure results in a near complete visual recovery that is achieved at 6 months and seems to remain stable for at least up to 6 years, said Fook Chang Lam, MD. » Read more results

FROM THE SHOW FLOOR

Ellex Medical Lasers has released a comprehensive e-book—"It's All About Outflow"—describing the role of canaloplasty in clinical practice. » More on the new e-book

TearScience introduced its new LipiView II system that assists clinicians in improving diagnosis of MGD with objective examination of patients' tear film lipid layer, blink profile, and now meibomian gland structure and function. » Read More on LipiView

Sightpath Medical announced a significant milestone—improving the sight of 2 million eyes. » Read more about the news